Skip to main content
. 2016 Feb 10;7(2):187–201. doi: 10.1007/s13300-016-0153-3

Fig. 2.

Fig. 2

A forward strategy for prevention of diabetes progression and diabetes-related complications. BOT basal-supported oral therapy, GLP-1 glucagon-like peptide 1, HbA 1c glycated hemoglobin, ICT intensified conventional therapy, SGLT2 sodium glucose co-transporter 2. Reprinted with permission from Markolf Hanefeld